在埃尔德海姆切斯特病的有效治疗:vemurafenib:一个病例报告
Ersin Bozan1, Tahir Darçın2, Samet Yaman2
1Department of Hematology and Bone Marrow Transplantation Center, Hematology and Bone Marrow Transplantation Unit, Health Sciences University Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey. ersinbozan87@gmail.com.
Journal of medical case reports
|October 11, 2023
概括
埃尔德海姆切斯特病 (ECD) 是一种罕见的多系统性疾病,通过向治疗有效治疗. 这一案例突显了BRAF V600E在ECD中的突变向治疗的显著反应.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 罕见疾病 罕见疾病
背景情况:
- 埃尔德海姆切斯特病 (ECD) 是一种罕见的多系统性参与的非朗格汉斯细胞囊炎.
- 全球报告的病例少于1000例,这表明人们对疾病的认识很低.
- 它的特点是它的稀有性和复杂的呈现.
更多相关视频
06:25Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
Published on: March 29, 2024
916
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
2.4K
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
